Background/Objectives: Heterogeneous imaging protocols, a lack of labeled data, and domain shifts continue to make training deep learning models to analyze medical images a challenge. This study presents ETDACVO (Enhanced Tasmanian Devil Anti-Conservative Variable Optimization), a hybrid evolutionary optimization system designed to improve convergence stability and cross-domain robustness in brain tumor MRI classification. Methods: ETDACVO combines Tasmanian Devil Optimization (TDO), Anti-Conservative Variable Optimization (ACVO), and Exponentially Weighted Moving Average (EWMA) smoothing to stabilize evolutionary parameter updates. Unlike existing approaches that optimize augmentation policies or optimizer dynamics separately, ETDACVO simultaneously evolves both components within a single evolutionary loop. The framework was evaluated on four MRI datasets (Nickparvar, Mendeley, BRISC, and Figshare), comprising 28,151 images. In addition, a convergence-aware explainability mechanism, CA-EA-GradCAM, was developed by integrating gradient saliency, transformer attention, and evolutionary convergence confidence to generate confidence-sensitive tumor localization maps. Results: Experimental results demonstrated that ETDACVO achieved a 2.3–2.5% improvement in classification accuracy and converged 19–22 epochs faster than baseline optimizers. The statistical significance of these improvements was confirmed using paired statistical tests (p < 1 × 10−5). Cross-dataset transfer experiments further showed strong domain-shift resilience, with performance retention reaching 92.8%. The proposed CA-EA-GradCAM mechanism provided interpretable and confidence-aware tumor localization maps. Conclusions: ETDACVO provides a robust and computationally efficient optimization framework for deep-learning-based medical image analysis. By jointly optimizing augmentation strategies and optimizer dynamics, the framework enhances convergence stability, cross-domain robustness, and interpretability, making it a promising approach for reliable brain tumor MRI classification under heterogeneous imaging conditions.
31 October 2026 in Journal of Computers, Mechanical and Management
In medical image analysis, transfer learning from ImageNet-pretrained models is a dominant paradigm, but its effectiveness on small clinical datasets is questionable. In this work, we challenge this understanding by showing that paradigms for natural image encoders can fundamentally fail to suit the medical imaging context for early disease detection, where data are scarce. We present MORSE (Morphological Observation with Reweighted Spectral Encoding), a minimal architecture that incorporates specific inductive biases by performing multi-scale morphological operations, adaptive gating of the spectrally decomposed signals, and memory-efficient hierarchical fusion. MORSE is evaluated on four clinical medical imaging tasks from dermatology, ophthalmology and neurology, and shows consistent improvements over eight state-of-the-art (SoTA) baselines trained from random initialization, as well as ImageNet-pretrained models and a RadImageNet-pretrained ResNet-50 (the only RadImageNet backbone tested). With limited training data, MORSE outperforms the strongest from-scratch baselines by 0.83 to 5.00 percentage points and exceeds the best pretrained models by 0.23 to 2.27 percentage points, whereas pure vision transformers underperform by approximately 16 to 45 percentage points on the three smaller datasets. Ablation studies support the complementary contributions of morphological and spectral features, and parameter analysis shows that architecture design using medical imaging priors can be more consequential than model capacity in the evaluated small-data settings. These studies challenge the prevailing reliance on transfer learning in data-constrained medical imaging, suggesting that domain-specific architectural innovation is a viable alternative for specialized diagnostic tasks.